	Prospectos 1 45 1 9725,	
apareci 1 45 1 9723,	
""1612"" 1 45 1 8252,	
rosa 1 45 1 8244,	
241 1 45 1 8219,	
eu/ 1 45 1 8189,	
europa 1 45 1 8188,	
emea 1 45 1 8187,	
//www 1 45 1 8186,	
(EMEA) 1 45 1 8184,	
Medicamentos 1 45 1 8183,	
Europea 1 45 1 8181,	
web 1 45 1 8177,	
página 1 45 1 8176,	
TEXTO 1 45 1 8165,	
REVISIÓN 1 45 1 8163,	
Junio 1 45 1 8156,	
AUTORIZACIÓN/RENOVACIÓN 1 45 1 8150,	
FECHA 2 45 2 8146,8160,	
EU/1/06/343/001 1 45 1 8142,	
EU/1/06/343/006 1 45 1 8141,	
EU/1/06/343/003 1 45 1 8139,	
NÚMERO(S) 1 45 1 8134,	
Unido 1 45 1 8132,	
Reino 1 45 1 8131,	
1DH 1 45 1 8130,	
Road 1 45 1 8127,	
Sanderson 1 45 1 8126,	
Uxbridge 2 45 2 8123,8128,	
PHARMA 1 45 1 8121,	
SQUIBB 1 45 1 8120,	
COMERCIALIZACIÓN 2 45 2 8118,8138,	
AUTORIZACIÓN 3 45 3 8116,8136,8153,	
LA 4 45 4 8115,8148,8152,8162,	
TITULAR 1 45 1 8113,	
normativa 1 45 1 8110,	
acuerdo 1 45 1 8107,	
realizará 1 45 1 8105,	
contacto 1 45 1 8101,	
materiales 1 45 1 8096,	
utilizado 1 45 1 8091,	
tamaños 1 45 1 8075,	
comercializados 1 45 1 8073,	
Puede 1 45 1 8069,	
polipropileno 1 45 1 8052,	
cierre 1 45 1 8050,	
(HDPE) 1 45 1 8048,	
densidad 1 45 1 8047,	
polietileno 1 45 1 8044,	
90 1 45 1 8017,	
perforadas 2 45 2 8009,8034,	
unitarias 2 45 2 8008,8033,	
Alu/Alu 2 45 2 8005,8030,	
blíster 2 45 2 8003,8028,	
láminas 2 45 2 8002,8027,	
película; 2 45 2 7998,8023,	
Cada 2 45 2 7989,8064,	
contenido 1 45 1 7986,	
cerrado 1 45 1 7981,	
frasco 2 45 2 7979,8068,	
Mantener 1 45 1 7977,	
25°C 1 45 1 7976,	
Frasco 3 45 3 7969,8042,8143,	
temperatura 2 45 2 7960,7973,	
Blíster 1 45 1 7956,	
conservación 1 45 1 7955,	
Precauciones 2 45 2 7952,8080,	
procede 1 45 1 7942,	
Polisorbato 1 45 1 7935,	
Macrogol 1 45 1 7933,	
titanio 1 45 1 7931,	
Dióxido 1 45 1 7929,	
pelicular 1 45 1 7928,	
Cubierta 1 45 1 7927,	
Povidona 1 45 1 7926,	
Celulosa 1 45 1 7924,	
Estearato 1 45 1 7921,	
monohidratada 1 45 1 7920,	
Crospovidona 1 45 1 7918,	
Núcleo 1 45 1 7915,	
	6 1 45 1 7910,	
FARMACÉUTICOS 1 45 1 7909,	
http 1 45 1 8185,	
conoce 1 45 1 7906,	
observaciones 1 45 1 7898,	
predictivo 1 45 1 7895,	
precisión 1 45 1 7892,	
establecidos 1 45 1 7890,	
pudieron 1 45 1 7888,	
adenomas 1 45 1 7870,	
hepáticos 2 45 2 7859,7873,	
carcinomas 2 45 2 7858,7872,	
macho/hembras 1 45 1 7857,	
cerebrales 1 45 1 7854,	
especie 1 45 1 7840,	
específico 1 45 1 7837,	
observados 1 45 1 7831,	
patogenia 1 45 1 7826,	
clave 1 45 1 7823,	
evento 1 45 1 7822,	
pulmón 1 45 1 7808,	
validez 1 45 1 7947,	
proliferación 1 45 1 7803,	
precedido 1 45 1 7800,	
hayan 1 45 1 8098,	
estuvo 1 45 1 7799,	
tumores 5 45 5 7775,7798,7829,7850,7863,	
carcinogenicidad 1 45 1 7761,	
Estudios 1 45 1 7759,	
considerablemente 1 45 1 7747,	
clastogénico 1 45 1 7739,	
reparación 1 45 1 7729,	
micronúcleos 1 45 1 7727,	
sirio 1 45 1 7724,	
embrionarias 1 45 1 7721,	
transformación 1 45 1 7718,	
mamífero 1 45 1 7717,	
microbiana 1 45 1 7712,	
mutagenicidad 2 45 2 7711,7713,	
Ames 1 45 1 7709,	
genotoxicidad 1 45 1 7700,	
demostró 1 45 1 7681,	
mg/kg 1 45 1 7679,	
lactantes 1 45 1 7674,	
progenie 1 45 1 7660,	
peri-postnatal 1 45 1 7650,	
13ª 1 45 1 7643,	
costillas 1 45 1 7619,	
lumbares 1 45 1 7617,	
vértebras 1 45 1 7616,	
(vértebras 1 45 1 7609,	
reducida 2 45 2 7608,7633,	
osificación 2 45 2 7607,7632,	
malformaciones 1 45 1 7601,	
fetal 2 45 2 7600,7684,	
(resorciones) 2 45 2 7596,7631,	
embriofetal 2 45 2 7595,7630,	
maternal 1 45 1 7593,	
gestantes 1 45 1 7560,	
conejos 2 45 2 7559,7622,	
evidentes 1 45 1 7547,	
roedores 1 45 1 7531,	
seminíferos) 1 45 1 7521,	
túbulos 1 45 1 7520,	
(degeneración 1 45 1 7517,	
hembra 3 45 3 7509,7868,7876,	
macho 3 45 3 7507,7767,7862,	
ratas 9 45 9 7506,7557,7585,7652,7672,7733,7815,7856,7875,	
reproducción 1 45 1 7482,	
diariamente 1 45 1 7464,	
administró 3 45 3 7462,7487,7669,	
monos 3 45 3 7457,7555,7818,	
especies 1 45 1 7454,	
respectivamente) 1 45 1 7439,	
19 1 45 1 7423,	
exposiciones 9 45 9 7422,7469,7512,7535,7577,7588,7625,7778,7879,	
estableció 1 45 1 7414,	
central 1 45 1 7409,	
toxicología 3 45 3 7394,7479,7526,	
preclínicos 1 45 1 7388,	
etnias 1 45 1 7383,	
estudiaron 1 45 1 7378,	
asiáticos 1 45 1 7373,	
caucásicos 1 45 1 7371,	
aplicarse 1 45 1 7367,	
conclusiones 1 45 1 7364,	
origen 1 45 1 7348,	
influya 2 45 2 7332,7354,	
identificó 2 45 2 7324,7346,	
poblacional 2 45 2 7309,7344,	
farmacocinético 3 45 3 7308,7330,7343,	
29% 1 45 1 7260,	
29 1 45 1 7249,	
jóvenes 3 45 3 7234,7267,7305,	
varones) 2 45 2 7231,7255,	
74 1 45 1 7229,	
(edad 2 45 2 7221,7245,	
83 1 45 1 7219,	
ancianos 3 45 3 7210,7263,7297,	
sujetos 4 45 4 7209,7233,7266,7380,	
comparando 1 45 1 7208,	
evaluó 1 45 1 7197,	
sexos 1 45 1 7194,	
hombres 1 45 1 7163,	
contribuyó 1 45 1 7137,	
alterada 1 45 1 7136,	
Post-trasplante 1 45 1 7092,	
(19 1 45 1 7089,	
5) 1 45 1 7088,	
(16 1 45 1 7087,	
(62 1 45 1 7081,	
(153 1 45 1 7079,	
35 1 45 1 7076,	
226 1 45 1 7070,	
588 1 45 1 7066,	
CLT/F 1 45 1 7065,	
(SD) 2 45 2 7064,7091,	
(10 1 45 1 7062,	
(31 1 45 1 7060,	
(78 1 45 1 7058,	
(101 1 45 1 7056,	
NA 2 45 2 7053,7054,	
135 1 45 1 7049,	
197 1 45 1 7047,	
383 1 45 1 7045,	
CLR 1 45 1 7044,	
(CV) 1 45 1 7043,	
/ml) 1 45 1 7042,	
(ng·h 1 45 1 7041,	
AUC(0-T) 1 45 1 7040,	
51 1 45 1 7030,	
(29 2 45 2 7026,7085,	
(56 1 45 1 7024,	
(37 1 45 1 7018,	
7) 4 45 4 7017,7021,7027,7080,	
(30 1 45 1 7016,	
(CV%) 1 45 1 7015,	
(ng/ml) 1 45 1 7002,	
Grave 3 45 3 6998,6999,7000,	
Moderado 1 45 1 6997,	
afectado 1 45 1 6995,	
farmacocinética 4 45 4 6972,7205,7336,7358,	
6) 3 45 3 7061,7082,7090,	
muestra 1 45 1 6970,	
Diálisis 1 45 1 6955,	
eliminó 2 45 2 6946,6961,	
Un 1 45 1 6939,	
moderada 1 45 1 6912,	
farmacocinéticos 1 45 1 6906,	
alrededor 1 45 1 6898,	
efectiva 1 45 1 6896,	
128 1 45 1 6871,	
terminal 1 45 1 6869,	
eliminación 3 45 3 6868,8083,8087,	
233 1 45 1 7036,	
biexponencial 1 45 1 6863,	
manera 1 45 1 6862,	
descendieron 1 45 1 6860,	
máximos 1 45 1 6854,	
neta 1 45 1 6848,	
glomerular 1 45 1 6844,	
sufre 1 45 1 6842,	
	BRISTOL-MYERS 1 45 1 8119,	
471 1 45 1 6834,	
360 1 45 1 6832,	
oscila 1 45 1 6830,	
independiente 2 45 2 6825,7664,	
aproximadamente 1 45 1 6815,	
orina 1 45 1 6808,	
recuperación 1 45 1 6803,	
Eliminación 1 45 1 6793,	
glucuronidados 1 45 1 6790,	
II 1 45 1 6789,	
fase 1 45 1 6788,	
conjugados 1 45 1 6786,	
acetilados 1 45 1 6778,	
oxidativos 1 45 1 6776,	
metabolitos 2 45 2 6775,6785,	
C14 1 45 1 6771,	
marcado 1 45 1 6769,	
Tras 1 45 1 6764,	
enzimático 1 45 1 6762,	
original 1 45 1 7968,	
13% 2 45 2 6750,6947,	
vitro 1 45 1 6748,	
in 1 45 1 6747,	
magnesio 1 45 1 7923,	
proteínas 1 45 1 6744,	
agua 1 45 1 6738,	
excede 1 45 1 6736,	
volumen 1 45 1 6730,	
Distribución 1 45 1 6728,	
afectar 1 45 1 6715,	
relevante 1 45 1 6702,	
consideró 1 45 1 6700,	
administra 1 45 1 6695,	
20% 1 45 1 6684,	
44 1 45 1 6672,	
ayunas) 1 45 1 6665,	
retraso 1 45 1 6647,	
dio 1 45 1 6643,	
g 2 45 2 6629,6640,	
54 1 45 1 6627,	
sulfatados 1 45 1 6792,	
kcal 2 45 2 6626,6637,	
comida 2 45 2 6620,6634,	
cola 1 45 1 7606,	
indistintamente 1 45 1 6609,	
usarse 1 45 1 6608,	
farmacéuticas 1 45 1 6606,	
demostraron 1 45 1 6596,	
alcanzan 2 45 2 6582,7754,	
respectivamente 2 45 2 6573,6589,	
ng/ml 2 45 2 6572,6588,	
aproximada 1 45 1 6546,	
acumulación 3 45 3 6545,6878,6895,	
alcanza 2 45 2 6530,6814,	
estacionario 2 45 2 6528,6558,	
perivascular 1 45 1 7403,	
repetida 1 45 1 6515,	
AUC 6 45 6 6511,6680,6690,7154,7257,7294,	
Cmáx 5 45 5 6509,6552,6670,6688,7001,	
proporcional 1 45 1 6501,	
estimado 2 45 2 6488,6733,	
inalterado 2 45 2 6485,6806,	
EEIG 1 45 1 8122,	
fármaco 3 45 3 6484,6805,6880,	
urinaria 1 45 1 6482,	
absoluta 1 45 1 6473,	
máximas 1 45 1 6462,	
plasmáticas 2 45 2 6461,6857,	
alcanzando 1 45 1 6459,	
rápidamente 1 45 1 6458,	
Absorción 1 45 1 6454,	
especificado 1 45 1 6449,	
año; 1 45 1 6444,	
entecavir-lamivudine 1 45 1 6333,	
(16%) 1 45 1 6315,	
13 3 45 3 6314,6338,6840,	
(10%) 1 45 1 6313,	
(8%) 1 45 1 6289,	
80 3 45 3 6281,6351,7936,	
187 1 45 1 6279,	
resume 1 45 1 6253,	
bajo) 1 45 1 6234,	
12 3 45 3 6227,6288,7299,	
(aumento 1 45 1 6225,	
rebote 2 45 2 6223,6445,	
Hasta 1 45 1 6213,	
baja 1 45 1 6206,	
existir 1 45 1 6204,	
seleccionar 1 45 1 6196,	
indicando 2 45 2 6188,7819,	
monitorizado 1 45 1 6185,	
refractarios 1 45 1 6173,	
(5%) 1 45 1 6171,	
10/187 1 45 1 6170,	
procedentes 1 45 1 6168,	
nivel 1 45 1 6164,	
ventana 2 45 2 6155,6438,	
sucesivas 2 45 2 6149,6432,	
confirmado 2 45 2 6146,6429,	
d 2 45 2 6145,6411,	
determinado 3 45 3 6142,6426,6477,	
punto 3 45 3 6134,6232,6418,	
Incremento 2 45 2 6128,6412,	
(3er 2 45 2 6119,6402,	
156 2 45 2 6118,6401,	
testiculares 2 45 2 7516,7546,	
año) 4 45 4 6110,6120,6393,6403,	
(22 1 45 1 7020,	
(2º 2 45 2 6109,6392,	
102 4 45 4 6108,6115,6391,6398,	
año); 2 45 2 6101,6384,	
(1er 2 45 2 6100,6383,	
58 4 45 4 6099,6105,6382,6388,	
Incluidos 2 45 2 6076,6359,	
plazo) 2 45 2 6064,6347,	
(seguidas 2 45 2 6057,6340,	
entecavir-lamivudina 1 45 1 6050,	
147 1 45 1 6041,	
virológico 3 45 3 6014,6224,6306,	
cantidades 1 45 1 6781,	
Rebote 2 45 2 6013,6305,	
acumulativa 2 45 2 6001,6296,	
Probabilidad 2 45 2 6000,6295,	
Genotípica 5 45 5 5998,6011,6262,6293,6303,	
ETVr 7 45 7 5997,6010,6019,6292,6302,6317,6440,	
1%) 3 45 3 5990,5993,5996,	
149 4 45 4 5983,6043,6068,6873,	
278 1 45 1 5982,	
663 1 45 1 5981,	
(33 1 45 1 7022,	
Emergente 6 45 6 5963,5999,6012,6263,6294,6304,	
(ETVr)Genotípica 1 45 1 5962,	
rtL180M) 1 45 1 5958,	
(rtM204 1 45 1 5956,	
alteración 1 45 1 7501,	
presencia 1 45 1 5946,	
similares 1 45 1 6916,	
Estas 1 45 1 5940,	
tabla) 1 45 1 5939,	
genotípicas 1 45 1 5911,	
evidencias 1 45 1 5910,	
identificaron 1 45 1 5909,	
determinación 3 45 3 5886,6082,6365,	
había 2 45 2 5880,6184,	
lamivudina) 1 45 1 5875,	
(resistentes 1 45 1 5873,	
nucleósidos) 1 45 1 5868,	
(sin 2 45 2 5864,6984,	
monitorizó 1 45 1 5847,	
(048) 1 45 1 5816,	
abierto 1 45 1 5815,	
marcha 1 45 1 5811,	
actualmente 1 45 1 5808,	
posible 1 45 1 5793,	
futuros 1 45 1 5776,	
elección 1 45 1 5773,	
consecuencias 1 45 1 5770,	
mutante 1 45 1 5763,	
selección 1 45 1 5761,	
monoterapia 1 45 1 5751,	
reducciones 1 45 1 5735,	
37% 1 45 1 5687,	
produjo 1 45 1 5684,	
inicialmente 2 45 2 5654,5855,	
incremento 2 45 2 5645,6500,	
adicional 1 45 1 5611,	
seguido 1 45 1 5607,	
17) 1 45 1 5603,	
placebo 1 45 1 5600,	
grupos 2 45 2 5585,7370,	
11 3 45 3 5578,5648,6286,	
(solo 1 45 1 5559,	
incluyeron 1 45 1 5520,	
incluía 1 45 1 5514,	
seguían 1 45 1 5509,	
recurrente 1 45 1 5505,	
(ARN 1 45 1 5496,	
estable 2 45 2 5493,7112,	
costilla 1 45 1 7644,	
controlado 1 45 1 5490,	
negativo 1 45 1 5483,	
67 1 45 1 5475,	
alterados 1 45 1 5694,	
reciben 2 45 2 5467,7109,	
Poblaciones 1 45 1 5460,	
Edad/Sexo 1 45 1 5426,	
40% 1 45 1 5396,	
77 1 45 1 5379,	
17% 1 45 1 5371,	
221 1 45 1 7038,	
30% 1 45 1 5352,	
considerable 1 45 1 5316,	
(79/253) 1 45 1 5299,	
(131/286) 1 45 1 5288,	
46% 2 45 2 5287,6674,	
027 1 45 1 5282,	
(68/93) 1 45 1 5270,	
73% 1 45 1 5269,	
respondieron 4 45 4 5264,5274,5293,5304,	
madres 1 45 1 7575,	
(83/111) 1 45 1 5259,	
75% 2 45 2 5258,6817,	
período 3 45 3 5249,6154,6437,	
022 1 45 1 5244,	
mantuvo 2 45 2 5240,5284,	
protocolo 1 45 1 5236,	
definidos 1 45 1 5233,	
cumplieron 1 45 1 5228,	
única 2 45 2 6887,6978,	
27% 1 45 1 5209,	
64% 1 45 1 5173,	
28 1 45 1 5152,	
26 3 45 3 5145,7536,8154,	
De 2 45 2 5143,5377,	
84% 1 45 1 5128,	
77% 1 45 1 5115,	
325) 1 45 1 5086,	
14% 1 45 1 7157,	
normalizó 3 45 3 5044,5197,5412,	
164 1 45 1 5023,	
243 1 45 1 5013,	
81% 2 45 2 5010,5418,	
semanas) 3 45 3 5008,5163,5394,	
extensión 2 45 2 6074,6357,	
(media 3 45 3 5005,5160,5391,	
52 3 45 3 5004,5159,5390,	
superando 3 45 3 5000,5156,5387,	
finalizar 1 45 1 4989,	
(3% 1 45 1 4982,	
355) 1 45 1 4943,	
HBsAg) 2 45 2 4935,4987,	
(5% 1 45 1 4930,	
31% 2 45 2 4917,5298,	
normalización 6 45 6 4913,4965,5109,5131,5366,5679,	
87% 1 45 1 4910,	
80% 1 45 1 4899,	
consiguió 3 45 3 4893,5087,5346,	
354) 1 45 1 4892,	
alternativo 1 45 1 4868,	
presentaron 4 45 4 4859,5028,5179,5397,	
siguieron 1 45 1 4826,	
respondían 1 45 1 4824,	
negativos) 1 45 1 4820,	
MEq/ml) 1 45 1 4800,	
(ADN 1 45 1 4794,	
segundo 1 45 1 4781,	
semana 15 45 15 4775,5003,5158,5389,5895,5966,6094,6104,6114,6215,6245,6266,6377,6387,6397,	
ratones 4 45 4 7766,7834,7861,7867,	
pre-establecidos 1 45 1 4771,	
criterios 4 45 4 4768,4786,4838,5230,	
Resultados 1 45 1 4752,	
3% 2 45 2 4709,6964,	
61%* 1 45 1 4703,	
19%* 1 45 1 4688,	
-0 1 45 1 4680,	
11* 1 45 1 4679,	
perdieron 1 45 1 5321,	
145 2 45 2 4672,7034,	
141 1 45 1 4671,	
26% 2 45 2 4668,4969,	
16% 1 45 1 4660,	
34% 1 45 1 4659,	
28% 1 45 1 4651,	
Resistentes 1 45 1 4644,	
145) 1 45 1 4632,	
100 3 45 3 4624,7072,7470,	
141) 2 45 2 4619,5345,	
lavado 1 45 1 4614,	
periodos 1 45 1 4612,	
cambiaron 1 45 1 4602,	
posteriores 1 45 1 4753,	
entrar 1 45 1 4597,	
presentaba 1 45 1 4586,	
85% 2 45 2 4582,5363,	
026) 2 45 2 4577,5332,	
aleatorizado 2 45 2 4564,5814,	
cuantificación 2 45 2 4551,4748,	
inferior 2 45 2 4549,4746,	
Amplicor 2 45 2 4546,4743,	
Cobas 2 45 2 4545,4742,	
Roche 2 45 2 4544,4741,	
Ensayo 2 45 2 4543,4740,	
c 10 45 10 4542,4739,5987,6009,6017,6121,6285,6301,6316,6404,	
variable 2 45 2 4538,4735,	
b 4 45 4 4536,4733,6075,6358,	
(puntuación 2 45 2 4527,4724,	
evaluable 2 45 2 4526,4723,	
p 2 45 2 4515,4712,	
*valor 2 45 2 4513,4710,	
21% 2 45 2 4511,5218,	
Seroconversión 2 45 2 4509,4706,	
LSN) 5 45 5 4508,4705,5051,5202,5415,	
continuaron 5 45 5 4621,4847,4996,5382,5573,	
71% 1 45 1 4507,	
60% 1 45 1 4505,	
68%* 1 45 1 4504,	
Normalización 2 45 2 4496,4695,	
PCR)c 2 45 2 4495,4694,	
300 12 45 12 4492,4553,4691,4750,4906,4958,5035,5100,5122,5186,5359,5404,	
refieren 2 45 2 6028,6326,	
72% 1 45 1 4490,	
67%* 1 45 1 4487,	
indetectable 2 45 2 4486,4687,	
copias/ml)c 2 45 2 4482,4683,	
79% 2 45 2 4962,5054,	
-4 2 45 2 4479,5673,	
04* 1 45 1 4478,	
-5 3 45 3 4475,4477,4678,	
86* 1 45 1 4474,	
-6 1 45 1 4473,	
Reducción 2 45 2 4468,4673,	
325 1 45 1 4466,	
355 1 45 1 4465,	
354 1 45 1 4464,	
15% 3 45 3 4459,4704,6299,	
12% 1 45 1 4458,	
8% 2 45 2 4456,4708,	
Empeoramiento 2 45 2 4451,4661,	
38% 1 45 1 4450,	
36% 2 45 2 4449,4488,	
35% 2 45 2 4448,6300,	
39% 3 45 3 4447,4951,5020,	
61% 1 45 1 4439,	
70%* 1 45 1 4438,	
62% 1 45 1 4437,	
72%* 1 45 1 4436,	
histológicab 2 45 2 4435,4649,	
Mejora 4 45 4 4434,4440,4648,4652,	
296 1 45 1 4433,	
314 2 45 2 4431,4432,	
n 4 45 4 4430,4463,4647,4670,	
022) 2 45 2 4418,4879,	
(log10 2 45 2 4481,4682,	
(ensayo 6 45 6 4417,4423,4576,4878,5072,5331,	
(LVD) 1 45 1 4411,	
compara 2 45 2 4408,5824,	
(ETV) 1 45 1 4406,	
aleatorizados 1 45 1 4399,	
e 2 45 2 4368,6439,	
características 1 45 1 4358,	
Independientemente 1 45 1 4355,	
positivo 1 45 1 4354,	
copias/ml) 5 45 5 4344,4554,4751,5501,5650,	
400 3 45 3 4343,5500,7934,	
(semana 1 45 1 4337,	
log10 6 45 6 4326,5649,5675,6130,6228,6414,	
DNA 2 45 2 4321,4339,	
pronunciada 1 45 1 4303,	
incluyó 1 45 1 5473,	
mejora 1 45 1 4300,	
130 1 45 1 6066,	
alta 2 45 2 4287,8046,	
Una 1 45 1 4284,	
39 1 45 1 4476,	
(todos 1 45 1 4277,	
comparable 1 45 1 4264,	
igual 1 45 1 4257,	
índice 6 45 6 4252,4442,4453,4654,4663,6876,	
empeoramiento 1 45 1 4235,	
preñadas 1 45 1 7673,	
Knodell 6 45 6 4228,4245,4256,4295,4534,4731,	
027) 2 45 2 4424,5073,	
necroinflamatoria 4 45 4 4226,4293,4532,4729,	
309 1 45 1 7068,	
puntos 1 45 1 4222,	
633 1 45 1 4197,	
comparador 1 45 1 4193,	
serológica 2 45 2 4181,4844,	
bioquímica 2 45 2 4179,4846,	
beneficio 1 45 1 4170,	
tasa 3 45 3 4159,4332,4945,	
gliomas 1 45 1 7853,	
menor 1 45 1 4158,	
mutada 1 45 1 4152,	
unión 2 45 2 4143,6742,	
secuenciadas 1 45 1 4133,	
000 1 45 1 4129,	
modesto 1 45 1 4105,	
monosustituciones 1 45 1 4088,	
741 1 45 1 4080,	
16 4 45 4 4078,7013,7319,8144,	
disminuyen 1 45 1 4072,	
V) 1 45 1 4071,	
rtM250I 1 45 1 4068,	
I; 1 45 1 4066,	
disminución 1 45 1 6686,	
S; 1 45 1 4061,	
L 2 45 2 4058,4069,	
I 1 45 1 4057,	
G 2 45 2 4056,4064,	
(rtT184A 1 45 1 4053,	
observadas 1 45 1 4048,	
susceptibilidad 1 45 1 4040,	
adicionales 2 45 2 4025,7620,	
Datos 1 45 1 7387,	
rtL180M 1 45 1 4005,	
rtM204V 1 45 1 4003,	
(LVDr) 1 45 1 3999,	
cepa 1 45 1 3990,	
emtricitabina 2 45 2 3982,5521,	
seis 1 45 1 3972,	
antagonizó 1 45 1 3963,	
amplio 1 45 1 3946,	
anti-VHB 1 45 1 3941,	
antagonizaron 1 45 1 3938,	
zidovudina 1 45 1 3936,	
estavudina 1 45 1 3933,	
didanosina 1 45 1 3931,	
funcionales 1 45 1 3924,	
grasas 1 45 1 6624,	
sensibilidad 4 45 4 3914,4018,4074,4108,	
M184V 2 45 2 3909,5764,	
altas 2 45 2 3896,7511,	
presión 1 45 1 3893,	
confirmando 1 45 1 3891,	
M184I 1 45 1 3890,	
seleccionaron 1 45 1 3887,	
cultivos 7 45 7 3881,3928,3968,3985,4044,4163,7741,	
estudio 6 45 6 3879,6072,6355,7550,7647,7663,	
virales 1 45 1 3875,	
títulos 1 45 1 3874,	
resultado 1 45 1 3850,	
dió 1 45 1 3848,	
experimentales 1 45 1 3847,	
condiciones 1 45 1 3846,	
tipos 2 45 2 3842,7848,	
VIH-1 1 45 1 3839,	
aislados 3 45 3 3836,4051,6167,	
cepas 1 45 1 3832,	
panel 1 45 1 3830,	
inhibitoria 2 45 2 3824,3894,	
sensibles 1 45 1 3816,	
siguen 1 45 1 3814,	
neumocitos 1 45 1 7805,	
rtN236T 1 45 1 3811,	
recombinantes 1 45 1 3802,	
059 1 45 1 3798,	
010 1 45 1 3795,	
(rango 1 45 1 3793,	
026 2 45 2 3791,3859,	
rtM204V) 1 45 1 3788,	
(rtL180M 1 45 1 3786,	
reversible 1 45 1 7404,	
LVDr 5 45 5 3785,4588,5955,6127,6410,	
mutantes 2 45 2 3780,3902,	
EC50 3 45 3 3772,3853,3869,	
75 2 45 2 6662,7321,	
silvestre 3 45 3 3768,3991,4086,	
transfectadas 1 45 1 3762,	
humanas 2 45 2 3761,6746,	
004 1 45 1 3756,	
concentración 1 45 1 3753,	
EC50) 1 45 1 3750,	
50% 1 45 1 3749,	
(reducción 1 45 1 3747,	
Actividad 1 45 1 3737,	
sanos; 1 45 1 6601,	
160 1 45 1 3735,	
Conservar 1 45 1 7964,	
(Ki 1 45 1 3733,	
HepG2 2 45 2 3732,3760,	
células 5 45 5 3731,3759,3844,7715,7720,	
mitocondrial 1 45 1 3729,	
(1%) 1 45 1 6311,	
relevantes 1 45 1 3719,	
313 1 45 1 4467,	
Además 1 45 1 3709,	
µM 3 45 3 3708,3757,3792,	
ADN-polimerasas 1 45 1 3696,	
débil 1 45 1 3693,	
TP 1 45 1 3689,	
M 2 45 2 3687,4059,	
0012 1 45 1 3686,	
ADN- 1 45 1 3679,	
Ki 2 45 2 3674,3703,	
síntesis 3 45 3 3664,3726,3742,	
(3) 1 45 1 3663,	
pregenómico 1 45 1 3661,	
mensajero 1 45 1 3660,	
puntuación 2 45 2 4241,4285,	
ARN 2 45 2 3659,5738,	
partir 1 45 1 3657,	
(-) 1 45 1 3653,	
cadena 2 45 2 3652,3667,	
transcripción 1 45 1 3648,	
(2) 1 45 1 3647,	
grasas) 2 45 2 6631,6642,	
(priming) 1 45 1 3641,	
cebado 1 45 1 3640,	
(1) 1 45 1 3639,	
funcionalmente 1 45 1 3631,	
entecavir-TP 2 45 2 3629,3676,	
desoxiguanosina-TP 1 45 1 3628,	
natural 1 45 1 3627,	
Al 3 45 3 3622,4988,5526,	
intracelular 1 45 1 3618,	
semivida 3 45 3 3617,6866,6893,	
(TP) 1 45 1 3612,	
trifosfato 1 45 1 3611,	
efizcamente 1 45 1 3606,	
fosforila 1 45 1 3605,	
acción 1 45 1 3588,	
Mecanismo 1 45 1 3586,	
filtración 1 45 1 6843,	
J05AF10 1 45 1 3585,	
ATC 1 45 1 3584,	
Código 1 45 1 3583,	
inversa 5 45 5 3582,3649,3978,4009,4149,	
transcriptasa 4 45 4 3581,3977,4008,4148,	
inhibidores 2 45 2 3578,3973,	
nucleótidos 1 45 1 3577,	
primaria 2 45 2 4541,4738,	
farmacoterapéutico 1 45 1 3574,	
Grupo 2 45 2 3573,7339,	
farmacodinámicas 1 45 1 3572,	
conservar 2 45 2 7958,7971,	
Propiedades 2 45 2 3571,6452,	
	5 1 45 1 3569,	
ESTE 1 45 1 3567,	
FARMACOLÓGICAS 1 45 1 3565,	
PROPIEDADES 1 45 1 3564,	
estándar 2 45 2 3561,6621,	
soporte 1 45 1 3560,	
crónica) 1 45 1 6987,	
recurrir 1 45 1 3555,	
fuera 1 45 1 3553,	
hubiera 1 45 1 3548,	
producirse 1 45 1 3539,	
inesperadas 1 45 1 3535,	
40 4 45 4 3529,3707,7051,7243,	
únicas 1 45 1 3526,	
Periodo 1 45 1 7945,	
14 3 45 3 3522,6312,7384,	
tasas 3 45 3 4894,5088,5347,	
períodos 2 45 2 3519,7492,	
20 4 45 4 3516,5674,6055,7241,	
sanos 2 45 2 3512,7128,	
voluntarios 3 45 3 3511,6600,7127,	
sobredosis 2 45 2 3509,3541,	
ningún 1 45 1 3506,	
9 8 45 8 3500,4324,4462,7029,7037,7048,8026,8145,	
subcutáneo 1 45 1 3498,	
tejido 1 45 1 3497,	
piel 1 45 1 3494,	
rash 1 45 1 3490,	
conocida 1 45 1 3489,	
aprobación 1 45 1 3486,	
siguientes 2 45 2 3475,7705,	
identificado 1 45 1 3473,	
identificadas 1 45 1 3466,	
además 1 45 1 3458,	
años) 2 45 2 3405,5459,	
65 4 45 4 3404,5458,5641,7217,	
clínicos) 2 45 2 3395,5447,	
respecto 4 45 4 3385,3987,4083,4229,	
aparentes 2 45 2 3376,5430,	
hubo 4 45 4 3374,5428,7190,7498,	
Sexo/edad 1 45 1 3372,	
similar 1 45 1 3355,	
incluían 1 45 1 3352,	
corporal 3 45 3 6739,7188,7292,	
actividad) 1 45 1 3350,	
Naturaleza 1 45 1 7984,	
(tratamiento 1 45 1 3346,	
regímenes 3 45 3 3343,5517,5777,	
podría 2 45 2 3316,6714,	
independientemente 1 45 1 3301,	
interrumpe 1 45 1 3300,	
perfectamente 1 45 1 7980,	
priori 1 45 1 3295,	
definida 1 45 1 3293,	
interrumpió 2 45 2 3286,4763,	
hizo 1 45 1 3250,	
les 2 45 2 3249,4864,	
limitado 2 45 2 3242,3335,	
número 3 45 3 3241,3334,5315,	
sólo 4 45 4 3239,4102,5942,7365,	
notificaron 1 45 1 3224,	
24/28) 1 45 1 3222,	
(86% 1 45 1 3221,	
tratamiento]) 1 45 1 3181,	
final 6 45 6 3179,5191,5204,5423,6152,6435,	
medición 1 45 1 3177,	
última 1 45 1 3176,	
basal 7 45 7 3170,4286,4525,4528,4722,4725,6165,	
[nivel 1 45 1 3169,	
referencia 1 45 1 3168,	
10% 2 45 2 3144,4457,	
Sobredosis 1 45 1 3501,	
6% 2 45 2 3135,6298,	
recibido 1 45 1 3129,	
incluido 1 45 1 3113,	
interrumpido 1 45 1 3103,	
agudas 1 45 1 3096,	
monitorización 3 45 3 3077,5984,6282,	
coincidió 1 45 1 3067,	
viral 5 45 5 3060,3638,4472,4677,5632,	
carga 4 45 4 3059,4471,4676,5631,	
vertebrales 1 45 1 7602,	
continuaban 1 45 1 3041,	
resolvieron 1 45 1 3039,	
semanas; 1 45 1 3035,	
comienzo 2 45 2 3021,3204,	
recibían 1 45 1 5710,	
medio 2 45 2 3018,5553,	
frente 14 45 14 2956,3001,3827,3955,4191,4516,4713,5061,5113,5216,5267,5296,5642,6659,	
produjeron 2 45 2 2931,2976,	
3x 1 45 1 2809,	
4% 2 45 2 2802,2958,	
envases 1 45 1 8077,	
relacionados 2 45 2 2706,2910,	
aspectos 2 45 2 2705,2909,	
nuevos 2 45 2 2704,2908,	
distribución 1 45 1 6732,	
reveló 2 45 2 2703,2907,	
crónico 2 45 2 2692,2896,	
48 12 45 12 2688,2892,4184,4338,4394,4642,4681,4756,4776,5309,5670,6349,	
monoinfección 1 45 1 3365,	
000/mm3 2 45 2 2676,2880,	
plaquetas 2 45 2 2673,2877,	
038 1 45 1 5472,	
recuento 4 45 4 2671,2875,5552,5565,	
11% 4 45 4 2668,3003,3254,4667,	
amilasa 2 45 2 2644,2848,	
494 1 45 1 5557,	
(Límite 2 45 2 4548,4745,	
presenta 1 45 1 4156,	
g/dl 1 45 1 2635,	
albúmina 1 45 1 2631,	
90%* 1 45 1 4489,	
observaron 11 45 11 2628,2845,3871,5944,6157,6774,7514,7544,7655,7697,7769,	
LSN 8 45 8 2619,2791,2837,2940,2985,3160,4318,4816,	
146 1 45 1 6280,	
superiores 1 45 1 2607,	
Business 1 45 1 8124,	
valores 6 45 6 2601,3700,3851,3865,6507,6550,	
1% 7 45 7 2597,2638,2679,2816,2883,4689,5928,	
asoció 1 45 1 4297,	
inicial 12 45 12 2594,2609,2626,2650,2665,2812,2828,2843,2854,2869,2946,2991,	
elevaciones 2 45 2 2586,3311,	
5% 5 45 5 2584,3400,5453,6006,7300,	
(LSN) 1 45 1 2569,	
normal 3 45 3 2568,6925,7132,	
rango 7 45 7 2567,3856,3947,6520,7213,7237,7315,	
superior 5 45 5 2565,2686,2890,7961,7974,	
límite 1 45 1 2564,	
> 26 45 26 2560,2574,2589,2604,2615,2621,2645,2660,2788,2793,2808,2823,2834,2839,2849,2864,2936,2942,2981,2987,3162,3403,3734,3861,4811,5457,	
Incompatibilidades 1 45 1 7940,	
2% 10 45 10 2551,2653,2779,2857,2949,2994,4924,4976,6004,6008,	
(con 1 45 1 7433,	
Desviaciones 2 45 2 2541,2769,	
3er 2 45 2 6025,6323,	
significativamente 3 45 3 5636,7333,7355,	
supresión 1 45 1 4790,	
psiquiátricos 2 45 2 2540,2768,	
parámetro 2 45 2 7329,7352,	
insomnio 2 45 2 2538,2766,	
lugar 3 45 3 2533,2761,6644,	
alteraciones 2 45 2 2530,2758,	
gastrointestinales 2 45 2 2526,2754,	
dispepsia 2 45 2 2524,2752,	
diarrea 2 45 2 2522,2750,	
nervioso 3 45 3 2519,2747,7408,	
Trastornos 9 45 9 2516,2525,2527,2539,2744,2753,2755,2767,3491,	
53 2 45 2 2510,4480,	
global 1 45 1 4268,	
exposición 7 45 7 2494,2724,3711,7095,7125,7142,7683,	
25% 2 45 2 3389,5441,	
HBeAg) 1 45 1 2485,	
(positivos 1 45 1 2481,	
Experiencia 7 45 7 2473,2710,3320,3456,4165,4372,4555,	
intervalo 1 45 1 2470,	
decreciente 1 45 1 2464,	
orden 1 45 1 2463,	
1/100 1 45 1 2454,	
solapamiento 1 45 1 4616,	
1/10); 1 45 1 2451,	
micromolares 2 45 2 3884,3961,	
( 11 45 11 2450,2453,3388,3399,4500,4699,5198,5413,5440,5452,7789,	
frecuente 8 45 8 2449,2452,2512,2520,2537,2742,2748,2765,	
definen 1 45 1 2446,	
órganos 1 45 1 2440,	
clasificación 1 45 1 2438,	
sistema 5 45 5 2436,2518,2746,6761,7407,	
enumeran 2 45 2 2433,2461,	
(3%) 1 45 1 2417,	
(4%) 1 45 1 2414,	
mareos 2 45 2 2413,2514,	
(6%) 2 45 2 2412,6287,	
(9%) 1 45 1 2410,	
cefalea 3 45 3 2409,2513,2743,	
relacionadas 2 45 2 2405,2426,	
posiblemente 2 45 2 2404,2425,	
consideradas 2 45 2 2400,2421,	
gravedad 2 45 2 2398,2466,	
año 6 45 6 4782,6026,6324,6448,7467,7553,	
comparables 1 45 1 2390,	
resultados 8 45 8 2383,2544,2772,4274,4391,4639,6023,6321,	
desviaciones 1 45 1 2380,	
incluidas 1 45 1 2378,	
perfiles 1 45 1 2371,	
ciego 4 45 4 2366,4401,4566,4853,	
periodo 3 45 3 2358,5610,6940,	
183) 1 45 1 2350,	
679) 1 45 1 2344,	
Park 1 45 1 8125,	
= 16 45 16 2343,2349,2354,4552,4618,4631,4749,4891,4942,5047,5085,5141,5344,5597,5602,7119,	
(n 13 45 13 2342,2348,2353,4617,4630,4890,4941,5084,5140,5343,5596,5601,7118,	
mg/día 3 45 3 2341,2347,3517,	
recibieron 2 45 2 2335,3514,	
720 1 45 1 2329,	
total 4 45 4 2326,2614,2833,6740,	
cuatro 1 45 1 2319,	
evaluación 1 45 1 2311,	
Reacciones 1 45 1 2308,	
8 9 45 9 2307,3897,4014,5547,6583,6638,7003,7039,8133,	
alterar 1 45 1 2298,	
somnolencia 2 45 2 2291,2515,	
fatiga 2 45 2 2289,2411,	
hámster 1 45 1 7723,	
Mareos 1 45 1 2288,	
tenga 1 45 1 2283,	
espera 1 45 1 2281,	
farmacodinámico 1 45 1 2276,	
perfil 6 45 6 2275,2487,2717,3327,3357,3379,	
Basándose 2 45 2 2272,6478,	
realizado 2 45 2 2257,5881,	
máquinas 3 45 3 2253,2271,2305,	
55%* 1 45 1 4650,	
capacidad 3 45 3 2248,2266,2300,	
Efectos 1 45 1 2245,	
excreción 3 45 3 2226,6481,7689,	
materna 2 45 2 2216,2232,	
leche 3 45 3 2215,2231,7694,	
excreta 1 45 1 2212,	
neonato 1 45 1 2203,	
(-3 1 45 1 5640,	
contenían 1 45 1 3906,	
impedir 1 45 1 2199,	
apropiadas 1 45 1 2197,	
recurrirse 1 45 1 2193,	
nacido 1 45 1 2188,	
biodisponibilidad 2 45 2 6472,6491,	
terapia 4 45 4 3307,3558,6048,6331,	
recién 1 45 1 2187,	
madre 1 45 1 2185,	
eficaces 1 45 1 2169,	
anticonceptivos 1 45 1 2168,	
métodos 1 45 1 2167,	
utilizar 4 45 4 2166,2252,2270,2304,	
fértil 1 45 1 2164,	
feto 1 45 1 2159,	
desarrollo 3 45 3 2157,5794,7796,	
riesgos 1 45 1 2153,	
suspender 1 45 1 3089,	
conocen 1 45 1 2151,	
claramente 1 45 1 2145,	
embarazo 1 45 1 2141,	
humanos 9 45 9 2134,2218,7432,7475,7541,7583,7744,7784,7903,	
seres 1 45 1 2133,	
potencial 1 45 1 2131,	
elevadas 5 45 5 2122,7589,7626,7749,7880,	
reproductiva 1 45 1 2119,	
toxicidad 7 45 7 2118,3551,7443,7592,7594,7629,7649,	
mostrado 1 45 1 2117,	
estudios 10 45 10 2113,2220,2258,3923,3951,7392,7448,7477,7524,7706,	
18% 2 45 2 2872,4512,	
utilización 2 45 2 2106,3480,	
suficientes 2 45 2 2103,7379,	
lactancia 2 45 2 2099,2237,	
Embarazo 1 45 1 2097,	
CYP450 2 45 2 2094,6763,	
mediadas 1 45 1 2092,	
(> 2 45 2 3156,4288,	
medicamentosas 1 45 1 2091,	
produzcan 1 45 1 2089,	
improbable 1 45 1 2084,	
(CYP450) 1 45 1 2076,	
P450 1 45 1 2075,	
citocromo 1 45 1 2074,	
enzimas 1 45 1 2072,	
precedió 1 45 1 3064,	
inhibidor 4 45 4 2069,3692,4145,6757,	
inductor 2 45 2 2067,6759,	
sustrato 3 45 3 2066,3626,6756,	
(hioides) 1 45 1 7634,	
abacavir 1 45 1 3930,	
actúa 2 45 2 2064,6754,	
ambas 1 45 1 6604,	
farmacocinéticas 2 45 2 2054,6453,	
interacciones 2 45 2 2053,2090,	
(1 1 45 1 6652,	
posibles 1 45 1 2046,	
estrechamente 1 45 1 2040,	
vigilarse 2 45 2 2039,3543,	
tipo 2 45 2 2035,3767,	
coadministra 1 45 1 2032,	
Si 2 45 2 2029,3296,	
excretan 1 45 1 2018,	
efectos 5 45 5 2008,2261,3717,7572,7656,	
disoproxil 2 45 2 2001,5524,	
1x 1 45 1 5414,	
tenofovir 4 45 4 2000,2061,3934,5523,	
dipivoxil 1 45 1 1998,	
adefovir 4 45 4 1997,2059,3810,5833,	
excepción 1 45 1 1994,	
A 5 45 5 1993,4854,5307,5623,7115,	
séricas 2 45 2 1987,6745,	
tubular 2 45 2 1981,6847,	
secreción 2 45 2 1980,6846,	
ensayo 7 45 7 4563,4600,5243,5281,5471,5529,5813,	
compiten 1 45 1 1977,	
negativamente 1 45 1 1970,	
afectan 2 45 2 1969,2024,	
coadministración 2 45 2 1965,2011,	
riñón 2 45 2 1959,6800,	
predominantemente 2 45 2 1956,6797,	
elimina 2 45 2 1955,6796,	
Dado 2 45 2 1951,2147,	
interacción 2 45 2 1950,3926,	
formas 2 45 2 1948,6605,	
histológica 4 45 4 4177,4214,4301,4369,	
medicamentos 6 45 6 1945,1967,1992,2015,2037,9727,	
M; 1 45 1 3863,	
Interacción 1 45 1 1941,	
encuentra 1 45 1 1930,	
incorporación 1 45 1 4022,	
personas 1 45 1 1928,	
glucosa-galactosa 1 45 1 1920,	
malabsorción 1 45 1 1918,	
Lapp 1 45 1 1916,	
89% 1 45 1 5106,	
lactasa 1 45 1 1914,	
deficiencia 1 45 1 1912,	
galactosa 1 45 1 1911,	
intolerancia 1 45 1 1908,	
raros 1 45 1 1906,	
microcristalina 1 45 1 7925,	
hereditarios 1 45 1 1905,	
9) 1 45 1 7120,	
problemas 1 45 1 1904,	
Lactosa 2 45 2 1884,7919,	
2x 5 45 5 2794,2835,2840,2943,2988,	
oportunas 1 45 1 1883,	
medidas 5 45 5 1880,2196,4272,6148,6431,	
tomando 1 45 1 1878,	
seguir 1 45 1 1877,	
transmisión 2 45 2 1868,2180,	
especial 1 45 1 8085,	
positivos) 1 45 1 4808,	
reduzca 1 45 1 1864,	
demostrado 2 45 2 1858,2224,	
advertirse 1 45 1 1850,	
generales 3 45 3 1848,2528,2756,	
Aspectos 1 45 1 1847,	
células/mm3) 2 45 2 1846,5570,	
200 2 45 2 1845,5569,	
celulares 8 45 8 1842,3698,3882,3929,3969,3986,4045,4164,	
recuentos 1 45 1 1841,	
bajos 2 45 2 1840,3867,	
limitada 1 45 1 1832,	
dispone 2 45 2 1813,1829,	
No 14 45 14 1811,2049,2100,2170,2233,2254,3502,5427,6994,7542,7695,7941,7957,7970,	
régimen 5 45 5 1803,2364,4852,5511,5576,	
bioequivalencia 1 45 1 6598,	
coinfección 2 45 2 1796,5464,	
68 1 45 1 1793,	
µM) 2 45 2 3736,3799,	
estudiado 2 45 2 1763,1791,	
Entecavir 6 45 6 1759,2062,3688,5961,6260,7737,	
TARGA 9 45 9 1758,1804,3345,5469,5512,5518,5712,5753,5778,	
estén 2 45 2 1756,8072,	
3) 1 45 1 2126,	
utilizarse 3 45 3 1747,2138,5787,	
96 8 45 8 2700,2904,4888,5007,5082,5162,5341,5393,	
(TARGA) 1 45 1 1737,	
1/10) 1 45 1 2456,	
actividad 6 45 6 1736,3597,3823,3940,3953,3965,	
gran 2 45 2 1735,3349,	
utilizó 1 45 1 1714,	
observado 5 45 5 1705,2052,4115,5759,6881,	
efectivo 2 45 2 1699,5728,	
test 2 45 2 7707,7725,	
estaban 5 45 5 1695,1730,1800,5724,5747,	
evaluado 3 45 3 1687,2006,5717,	
antirretroviral 4 45 4 1682,1733,1787,3347,	
313) 1 45 1 5142,	
simultáneamente 6 45 6 1680,1697,1785,5468,5711,5726,	
2006 1 45 1 8158,	
recibiendo 8 45 8 1679,1696,1731,1757,1784,1801,5725,5748,	
VIH/VHB 10 45 10 1675,1692,1753,1781,1798,3340,5465,5707,5721,5745,	
coinfectados 12 45 12 1673,1690,1751,1779,1825,1835,3323,3338,5484,5705,5720,5743,	
infectados 2 45 2 1662,7105,	
27 1 45 1 7028,	
co- 1 45 1 1661,	
existen 2 45 2 1652,2101,	
D 2 45 2 1650,1671,	
C 4 45 4 1648,1669,4054,4063,	
Coinfección 1 45 1 1645,	
(945 1 45 1 6625,	
tacrolimus 2 45 2 1640,7117,	
acumulada 4 45 4 4897,4948,5091,5350,	
ciclosporina 2 45 2 1638,7114,	
minuciosamente 1 45 1 1621,	
presentan 3 45 3 4010,4389,4637,	
evaluarse 1 45 1 1620,	
receptores 3 45 3 1611,1631,7100,	
hay 2 45 2 1598,2171,	
69 3 45 3 2739,7032,7225,	
hepático 5 45 5 1597,1615,1635,7093,7104,	
trasplante 4 45 4 1596,1614,1634,7103,	
Blister 1 45 1 8140,	
esclarecido 1 45 1 1588,	
plazo 1 45 1 1581,	
(+) 1 45 1 3668,	
clínica 3 45 3 1578,4166,5841,	
importancia 1 45 1 1577,	
apareció 1 45 1 1564,	
presente 2 45 2 1556,9715,	
rtM250 5 45 5 1553,4032,4095,5924,9712,	
emergente 4 45 4 6020,6239,6318,6441,	
rtS202 6 45 6 1551,4030,4062,4093,5922,9710,	
derivada 2 45 2 1544,9703,	
previamente 4 45 4 1536,4308,4349,9695,	
respuestas 2 45 2 4176,4366,	
pequeño 2 45 2 1529,9688,	
envase 4 45 4 7967,7988,7990,8065,	
porcentaje 2 45 2 1528,9687,	
detectar 3 45 3 1524,2045,9683,	
tratar 1 45 1 1716,	
análisis 5 45 5 1521,3820,7307,7342,9680,	
realizarse 2 45 2 1520,9679,	
población 2 45 2 1504,9663,	
(ETVr) 7 45 7 1501,1543,5919,6162,6261,9660,9702,	
asociadas 2 45 2 1495,9654,	
doble 4 45 4 2365,4400,4565,6548,	
incluyendo 2 45 2 1493,9652,	
secundarias 2 45 2 1492,9651,	
(cirrosis) 1 45 1 4260,	
posterior 3 45 3 1488,5898,9647,	
conducir 5 45 5 1485,2250,2268,2302,9644,	
podrían 3 45 3 1484,2297,9643,	
Metabolismo 1 45 1 6751,	
sustituciones 14 45 14 1478,1491,1546,4002,4047,4119,5913,5941,5949,6158,6198,9637,9650,9705,	
codifican 2 45 2 1477,9636,	
polimerasa 7 45 7 1472,3601,3637,3644,3680,3722,9631,	
específica 2 45 2 1462,9621,	
analíticos 2 45 2 1453,9612,	
marcadores 2 45 2 1452,9611,	
mejoría 3 45 3 1449,4213,9608,	
cambios 5 45 5 1441,4024,7515,7545,9600,	
(INTIs) 1 45 1 3979,	
asegurarse 2 45 2 1437,9596,	
médicos 2 45 2 1435,9594,	
potencialmente 2 45 2 1428,9587,	
diferenciar 2 45 2 1415,9574,	
riguroso 2 45 2 1413,9572,	
F 1 45 1 4055,	
Estos 2 45 2 1408,9567,	
factores 2 45 2 1401,9560,	
u 2 45 2 1399,9558,	
obesas) 2 45 2 1395,9554,	
mujeres 9 45 9 1394,2110,2161,3391,5443,7160,7224,7248,9553,	
aminoácidos 1 45 1 4028,	
VIH 16 45 16 1702,1709,1727,1770,1827,1837,3325,3904,3957,5486,5495,5498,5731,5740,5766,5798,	
particular 2 45 2 1392,9551,	
prescriben 2 45 2 1383,9542,	
precaución 5 45 5 1380,1461,1882,9539,9620,	
actuarse 2 45 2 1378,9537,	
ofreció 1 45 1 4865,	
sérico 2 45 2 1376,9535,	
lactato 2 45 2 1375,9534,	
rtT184 5 45 5 1550,4029,4092,5921,9709,	
hepático/esteatosis 2 45 2 1368,9527,	
fallo 4 45 4 1367,1370,9526,9529,	
pancreatitis 2 45 2 1366,9525,	
asociaron 4 45 4 1364,3053,4329,9523,	
desenlace 2 45 2 1361,9520,	
veces 23 45 23 1359,2562,2576,2591,2606,2617,2623,2647,2662,3158,3164,4015,4081,4814,6884,7123,7426,7471,7537,7579,7780,7791,9518,	
indicar 2 45 2 1349,9508,	
abdominal 2 45 2 1347,9506,	
dolor 2 45 2 1346,9505,	
embriotoxicidad 1 45 1 7570,	
vómitos 4 45 4 1344,2521,2749,9503,	
vasculares 1 45 1 7864,	
benignos 3 45 3 1340,7865,9499,	
digestivos 2 45 2 1339,9498,	
etiología 2 45 2 1335,9494,	
metabólica/láctica 2 45 2 1333,9492,	
progresiva 2 45 2 1330,9489,	
log10/ml 1 45 1 3062,	
transaminasas 4 45 4 1328,1420,9487,9579,	
rápida 2 45 2 1325,9484,	
CD4 3 45 3 1843,5555,5567,	
observa 3 45 3 1322,6498,9481,	
Debe 4 45 4 1312,1377,9471,9536,	
descartarse 2 45 2 1309,9468,	
Como 2 45 2 1300,9459,	
análogos 6 45 6 1297,1317,1384,9456,9476,9543,	
78%* 1 45 1 4506,	
mortal 4 45 4 1284,1362,9443,9521,	
hipoxemia) 2 45 2 1281,9440,	
acidosis 8 45 8 1276,1332,1353,1432,9435,9491,9512,9591,	
grave 5 45 5 1268,1289,6914,9427,9448,	
hepatomegalia 8 45 8 1267,1288,1329,1397,9426,9447,9488,9556,	
administraba 1 45 1 7565,	
láctica 8 45 8 1265,1277,1354,1433,9424,9436,9513,9592,	
Acidosis 2 45 2 1264,9423,	
(379 1 45 1 6636,	
51) 1 45 1 5598,	
frecuencia 5 45 5 1263,2472,3487,6207,9422,	
PRIMERA 1 45 1 8149,	
apropiados 4 45 4 1260,1522,9419,9681,	
controles 2 45 2 1259,9418,	
someterse 2 45 2 1256,9415,	
peso 5 45 5 7174,7187,7279,7291,7599,	
finalizado 2 45 2 1252,9411,	
nucleósido 3 45 3 1306,3592,9465,	
síntomas 4 45 4 1242,1338,9401,9497,	
presenten 2 45 2 1241,9400,	
interrumpa 2 45 2 1225,9384,	
funciones 2 45 2 1208,9367,	
asociados 4 45 4 1202,1285,9361,9444,	
serológicos 2 45 2 1201,9360,	
virológicos 2 45 2 1199,9358,	
parámetros 3 45 3 1197,6905,9356,	
regularmente 2 45 2 1195,9354,	
controlarse 2 45 2 1194,9353,	
inicio 13 45 13 1183,1558,2580,2798,3173,3451,4231,4262,4590,5527,6992,9342,9717,	
7 9 45 9 1181,2244,3319,3449,4799,7035,7077,8112,9340,	
Child-Pugh 3 45 3 1180,3448,9339,	
Lista 1 45 1 7912,	
escala 8 45 8 1179,3447,4225,4238,4292,4531,4728,9338,	
valoración 3 45 3 1176,3444,9335,	
repetidas 3 45 3 7397,7451,7529,	
tenían 5 45 5 1174,4280,5489,5563,9333,	
observación 3 45 3 1167,3436,9326,	
absorbe 1 45 1 6457,	
comparación 3 45 3 1158,3427,9317,	
hepáticas 3 45 3 1155,3424,9314,	
adversas 13 45 13 1154,2048,2294,2309,2315,2393,2420,2459,3423,3462,3477,3534,9313,	
reacciones 12 45 12 1153,2047,2293,2314,2392,2419,2458,3422,3461,3476,3533,9312,	
elevada 4 45 4 1151,3420,3712,9310,	
incidencia 7 45 7 1149,3309,3418,7640,7773,7845,9308,	
Hipromelosa 1 45 1 7932,	
observó 10 45 10 1147,3416,7401,7446,7569,7591,7628,7813,7842,9306,	
descompensada 10 45 10 1140,1145,1192,3409,3414,5807,5822,9299,9304,9351,	
resistencias 3 45 3 1525,5796,9684,	
justificada 2 45 2 1136,9295,	
reanudación 2 45 2 1127,9286,	
determinados 2 45 2 1124,9283,	
interrumpir 2 45 2 1116,9275,	
meses 4 45 4 1113,1233,9272,9392,	
mínimo 4 45 4 1110,3171,6648,9269,	
laboratorio 6 45 6 1107,2388,2549,2777,3834,9266,	
clínico 4 45 4 1102,4171,7758,9261,	
seguimiento 10 45 10 1101,1412,3184,3237,3252,3275,5251,5312,9260,9571,	
mediante 2 45 2 1099,9258,	
periódicos 2 45 2 1098,9257,	
monitorizarse 4 45 4 1095,1512,9254,9671,	
notificó 2 45 2 1082,9241,	
24 12 45 12 1076,3214,4828,5254,5605,5613,5625,5896,6095,6378,6900,9235,	
23 3 45 3 1074,3212,9233,	
prueba 1 45 1 8054,	
adversos 2 45 2 3718,7657,	
relacionado 2 45 2 1429,9588,	
media 10 45 10 1063,2508,2698,2737,2902,3770,5544,7222,7246,9222,	
letales 2 45 2 1049,9208,	
graves 7 45 7 1047,1156,1357,3425,9206,9315,9516,	
casos 11 45 11 1044,1125,1274,1356,3051,5756,5790,9203,9284,9433,9515,	
notificado 7 45 7 1043,1273,3094,3505,5734,9202,9432,	
Leve 1 45 1 6996,	
embargo 4 45 4 1040,7362,7882,9199,	
Sin 5 45 5 1039,4425,7361,7881,9198,	
espontáneamente 2 45 2 1038,9197,	
remitir 2 45 2 1037,9196,	
parece 2 45 2 1036,9195,	
mayoría 7 45 7 1035,1080,3048,3218,4361,9194,9239,	
elevación 4 45 4 1025,1324,9184,9483,	
normalmente 4 45 4 1022,1286,9181,9445,	
asocian 4 45 4 1021,1446,9180,9605,	
potenciales 1 45 1 2154,	
post-tratamiento 9 45 9 1019,1071,3185,3276,3315,5252,5313,9178,9230,	
presentaban 2 45 2 5503,5550,	
Las 8 45 8 1017,2391,2418,2443,2457,4046,4087,9176,	
suspendido 2 45 2 1010,9169,	
comunicado 2 45 2 1000,9159,	
distribuido 2 45 2 7999,8024,	
dichas 1 45 1 6197,	
También 2 45 2 997,9156,	
supervisión 2 45 2 993,9152,	
estrecha 2 45 2 992,9151,	
deben 13 45 13 989,1193,1255,1436,1519,1876,1922,2165,9148,9352,9414,9595,9678,	
consiguiente 4 45 4 988,2082,6603,9147,	
Agencia 1 45 1 8180,	
reagudización 4 45 4 982,1002,9141,9161,	
postcomercialización 1 45 1 3457,	
riesgo 8 45 8 976,1311,1403,1866,2130,9135,9470,9562,	
mayor 11 45 11 975,1262,3318,4336,5637,7158,7261,7301,7844,9134,9421,	
cirrosis 10 45 10 971,1139,1144,1191,3408,3413,9130,9298,9303,9350,	
asignados 2 45 2 5582,5655,	
descompensación 4 45 4 966,978,9125,9137,	
rtA181V 1 45 1 3813,	
embarazadas 1 45 1 2111,	
bilirrubina 4 45 4 962,2613,2832,9121,	
perros 3 45 3 7399,7533,7816,	
concentraciones 15 45 15 959,1986,2629,2642,2657,2846,2861,3883,3898,3949,3960,6460,6856,7746,9118,	
frecuencias 2 45 2 2442,2444,	
aumento 11 45 11 956,1373,1417,3023,3070,3206,7139,7637,9115,9532,9576,	
acompañados 2 45 2 953,9112,	
general 5 45 5 952,1510,3037,9111,9669,	
semanas 31 45 31 935,1077,1575,2362,2511,2689,2701,2740,2893,2905,3215,4185,4395,4643,4757,4829,4889,5083,5255,5310,5342,5606,5614,5626,5671,5937,6056,6339,7496,9094,9236,	
aparición 10 45 10 924,1068,1351,1489,1707,7614,9083,9227,9510,9648,	
descenso 4 45 4 4012,4219,6667,6677,	
mediana 5 45 5 919,3199,6053,6336,9078,	
definió 1 45 1 4216,	
habían 3 45 3 1533,5535,9692,	
tratados 40 45 40 915,1053,1535,1636,2953,2962,2998,3007,3013,3139,3148,3189,3258,3265,3341,4307,4348,4593,4938,5015,5025,5058,5066,5137,5147,5153,5168,5176,5213,5221,5532,5620,5854,5932,5978,6176,6276,9074,9212,9694,	
séricos 2 45 2 903,9062,	
aumentar 3 45 3 895,1984,9054,	
antiviral 6 45 6 890,1215,3738,3954,9049,9374,	
iniciar 2 45 2 887,9046,	
Después 5 45 5 885,6849,7175,7280,9044,	
ALT 35 45 35 883,892,946,1444,2559,2588,2603,2787,2807,2821,2935,2980,3026,3073,3155,3209,3272,3314,4315,4499,4698,4810,4916,4968,5042,5112,5134,5195,5369,5410,5682,9042,9051,9105,9603,	
mg) 1 45 1 7794,	
transitorios 2 45 2 878,9037,	
caracterizan 2 45 2 875,9034,	
rica 1 45 1 6622,	
frecuentes 4 45 4 872,2295,2395,9031,	
relativamente 2 45 2 871,9030,	
son 4 45 4 870,2292,6566,9029,	
reagudizaciones 11 45 11 863,926,1018,1046,1070,3095,9022,9085,9177,9205,9229,	
Reagudizaciones 4 45 4 858,2914,3086,9017,	
conteniendo 1 45 1 1805,	
especiales 5 45 5 803,5461,7953,8081,8962,	
precauciones 2 45 2 802,8961,	
Advertencias 2 45 2 800,8959,	
activo 3 45 3 791,4194,8950,	
principio 2 45 2 790,8949,	
68% 1 45 1 5063,	
Hipersensibilidad 2 45 2 788,8947,	
Contraindicaciones 2 45 2 787,8946,	
insuficiencia 8 45 8 783,812,1244,6910,7134,8942,8971,9403,	
residuos 3 45 3 1549,4091,9708,	
** 2 45 2 759,8918,	
* 2 45 2 747,8906,	
72 2 45 2 745,8904,	
aumentos 12 45 12 877,943,2556,2784,2804,2932,2977,3152,3269,7770,9036,9102,	
días 6 45 6 740,762,3523,6535,8899,8921,	
linfocitos 1 45 1 7743,	
diferencias 7 45 7 3375,5429,7167,7179,7191,7272,7284,	
5-7 2 45 2 739,8898,	
DPAC** 2 45 2 734,8893,	
ó 6 45 6 732,733,5046,5869,8891,8892,	
Hemodiálisis 2 45 2 730,8889,	
detallada 1 45 1 8168,	
Cmín 1 45 1 6554,	
05 4 45 4 717,4520,4717,8876,	
PCR 15 45 15 4547,4744,4909,4961,5038,5103,5125,5189,5362,5407,5888,6084,6144,6367,6428,	
10 18 45 18 715,2561,2789,2937,2982,3157,3862,5834,6220,6534,7005,7007,7425,7678,8011,8036,8159,8874,	
15 6 45 6 701,3620,6290,7009,7011,8860,	
día* 10 45 10 691,706,713,722,729,8850,8865,8872,8881,8888,	
25 4 45 4 686,4813,7253,8845,	
30-49 2 45 2 684,8843,	
(ml/min) 5 45 5 667,6993,7055,7078,8826,	
Resistencia 8 45 8 663,1459,3983,5840,5959,6258,8822,9618,	
Aclaramiento 3 45 3 657,6988,8816,	
Baraclude* 2 45 2 656,8815,	
rigurosamente 6 45 6 653,857,1514,8812,9016,9673,	
monitorizada 4 45 4 652,856,8811,9015,	
respuesta 26 45 26 648,852,1214,1424,1516,3292,3304,4247,4267,4334,4770,4788,4840,4861,4896,4947,5090,5232,5238,5323,5349,8807,9011,9373,9583,9675,	
sustitución 2 45 2 3889,3908,	
Por 8 45 8 644,848,1742,2081,2189,5781,8803,9007,	
ligera 1 45 1 6635,	
clínicamente 5 45 5 643,847,6701,8802,9006,	
evaluadas 4 45 4 642,846,8801,9005,	
sometidas 1 45 1 7586,	
desconocida 2 45 2 1336,9495,	
sido 10 45 10 641,845,1534,1686,1762,1790,5716,8800,9004,9693,	
falanges) 1 45 1 7612,	
sugiere 2 45 2 6838,6891,	
10) 1 45 1 4289,	
(en 6 45 6 1278,1391,4805,4817,9437,9550,	
han 22 45 22 640,844,1009,1042,1272,2005,2051,2116,2223,2256,3093,3102,3128,3472,3504,4114,5733,8799,9003,9168,9201,9431,	
limitados 5 45 5 633,837,1600,8792,8996,	
8) 6 45 6 911,1090,7023,7057,9070,9249,	
extrapolación 5 45 5 630,834,7901,8789,8993,	
basados 4 45 4 627,831,8786,8990,	
están 6 45 6 626,830,1678,1783,8785,8989,	
propuestos 4 45 4 625,829,8784,8988,	
ajustes 4 45 4 622,826,8781,8985,	
Los 31 45 31 621,825,968,1238,1337,1355,1901,2112,2219,3510,3800,3901,4311,4785,4821,4833,5487,5516,5571,6022,6122,6320,6405,6549,6590,8780,8984,9127,9397,9496,9514,	
dosificación 2 45 2 613,8772,	
intervalos 4 45 4 611,1097,8770,9256,	
21 1 45 1 7578,	
aumentando 2 45 2 609,8768,	
alternativa 2 45 2 605,8764,	
guanosina 1 45 1 3595,	
disponible 4 45 4 601,1931,8173,8760,	
estuviera 2 45 2 600,8759,	
caso 8 45 8 593,1221,3507,3537,3777,6705,8752,9380,	
tabla 8 45 8 589,620,4387,4635,6257,6967,8748,8779,	
detalla 2 45 2 586,8745,	
según 3 45 3 584,2434,8743,	
solución 8 45 8 582,597,757,1933,6594,8741,8756,8916,	
(60 1 45 1 7083,	
utilizando 3 45 3 578,3840,8737,	
diaria 4 45 4 577,1896,6888,8736,	
precisan 2 45 2 1410,9569,	
(DPAC) 3 45 3 569,6959,8728,	
correspondían 1 45 1 7420,	
continua 3 45 3 568,6958,8727,	
local 1 45 1 8111,	
ambulatoria 3 45 3 567,6957,8726,	
inhibe 2 45 2 3630,3740,	
peritoneal 3 45 3 566,6956,8725,	
alcanzaban 1 45 1 3290,	
diálisis 2 45 2 565,8724,	
reducción 7 45 7 573,3056,4140,5628,5663,7597,8732,	
hemodiálisis 7 45 7 563,764,771,6942,8722,8923,8930,	
sometidos 3 45 3 561,7623,8720,	
aquéllos 2 45 2 560,8719,	
Receptores 1 45 1 1594,	
incluidos 3 45 3 559,7455,8718,	
ml/min 3 45 3 558,6835,8717,	
50 7 45 7 557,670,2675,2879,7074,8716,8829,	
experimentaron 4 45 4 3151,3268,3532,6222,	
< 27 45 27 556,714,750,2455,2596,2632,2637,2674,2678,2815,2878,2882,4342,4797,4905,4957,5034,5099,5121,5185,5358,5403,5499,5568,8715,8873,8909,	
Se 16 45 16 544,570,1703,1828,2127,2207,2627,2844,3074,5732,6156,6497,7513,7841,8703,8729,	
máximo 3 45 3 4886,5080,5339,	
creatinina 10 45 10 539,555,666,6938,6990,7184,7289,8698,8714,8825,	
disminuir 3 45 3 534,6934,8693,	
disminuye 4 45 4 532,4038,6932,8691,	
aclaramiento 11 45 11 529,536,553,6822,6929,6936,7182,7287,8688,8695,8712,	
Insuficiencia 8 45 8 526,772,806,6902,6926,8685,8931,8965,	
etnia 2 45 2 525,8684,	
sexo 4 45 4 522,3387,5439,8681,	
ajuste 4 45 4 516,817,8675,8976,	
étnico 4 45 4 511,7340,7349,8670,	
Sexo 3 45 3 508,7152,8667,	
renal"" 2 45 2 503,8662,	
lipasa 2 45 2 2659,2863,	
""Insuficiencia 2 45 2 502,8661,	
recomendaciones 2 45 2 498,8657,	
dependiendo 2 45 2 490,8649,	
ajustarse 2 45 2 489,8648,	
náuseas 5 45 5 1343,2416,2523,2751,9502,	
análogo 3 45 3 1304,3593,9463,	
La 21 45 21 486,1091,1576,1616,2310,3673,3769,4021,4134,4246,5194,6235,6471,6610,6685,6741,7133,8086,8166,8645,9250,	
edad 10 45 10 483,2163,3398,5451,7202,7215,7239,7317,7326,8642,	
función 20 45 20 480,493,520,1092,1163,1617,1973,2027,3081,3432,5437,6923,7130,7170,7275,8639,8652,8679,9251,9322,	
ajustar 10 45 10 476,546,606,777,7177,7282,8635,8705,8765,8936,	
fumarato 2 45 2 2002,5525,	
necesario 8 45 8 475,514,776,2146,3554,8634,8673,8935,	
Ancianos 3 45 3 472,7195,8631,	
seguridad 16 45 16 469,636,840,1606,2373,2489,2709,2719,2913,3329,3359,3381,7390,8628,8795,8999,	
ausencia 5 45 5 465,1279,4117,8624,9438,	
debido 9 45 9 462,1421,5791,6015,6307,7164,7269,8621,9580,	
18 5 45 5 460,3705,6682,8581,8619,	
menores 4 45 4 458,3876,6782,8617,	
anti-HIV 1 45 1 3966,	
niños 3 45 3 457,8056,8616,	
recomendado 2 45 2 453,8612,	
adolescentes 2 45 2 449,8608,	
Niños 2 45 2 447,8606,	
paciente 8 45 8 446,485,496,3545,5780,8605,8644,8655,	
apropiado 2 45 2 443,8602,	
principalmente 1 45 1 7268,	
actividades 2 45 2 2287,3634,	
sigue 2 45 2 441,8600,	
continuar 2 45 2 438,8597,	
asegurar 2 45 2 436,8595,	
probablemente 1 45 1 7836,	
858) 1 45 1 2355,	
periódica 3 45 3 434,3078,8593,	
reevaluación 2 45 2 433,8592,	
indica 2 45 2 617,8776,	
recomienda 13 45 13 431,545,571,755,815,1774,2235,3075,8590,8704,8730,8914,8974,	
años 12 45 12 429,461,5548,7220,7226,7244,7250,7322,7764,7949,8588,8620,	
prolongados 2 45 2 424,8583,	
tratamientos 2 45 2 423,8582,	
Con 2 45 2 421,8580,	
esteatosis 4 45 4 1270,1291,9429,9450,	
10-29 2 45 2 699,8858,	
negativos 11 45 11 398,1086,1824,2483,3228,4420,5071,5320,7736,8557,9245,	
4) 8 45 8 394,3121,3371,3920,5802,7025,7151,8553,	
eficacia 18 45 18 390,420,471,638,842,1603,1656,1818,4276,4540,4737,5433,6718,8549,8579,8630,8797,9001,	
basales 3 45 3 4313,4359,5693,	
pérdida 8 45 8 388,418,3912,4802,4933,4985,8547,8577,	
haya 4 45 4 385,415,8544,8574,	
HBs 4 45 4 381,411,8540,8570,	
meses) 2 45 2 376,8535,	
- 15 45 15 374,3033,3213,3796,6467,6523,6533,6653,6673,6683,6833,6872,7218,7242,8533,	
separadas 2 45 2 368,8527,	
esternón 1 45 1 7610,	
suero 2 45 2 367,8526,	
consecutivas 2 45 2 365,8524,	
muestras 3 45 3 364,4130,8523,	
anticuerpos 2 45 2 360,8519,	
detección 2 45 2 358,8517,	
ADN 27 45 27 353,905,1030,3655,3670,3728,3744,4483,4684,4902,4954,5031,5096,5118,5182,5355,5400,5665,5890,6086,6139,6369,6423,7731,8512,9064,9189,	
HBe 4 45 4 347,361,8506,8520,	
seroconversión 12 45 12 346,380,410,4920,4927,4972,4979,5374,5701,8505,8539,8569,	
cumplían 2 45 2 4766,4836,	
(pérdida 2 45 2 348,8507,	
produzca 4 45 4 344,408,8503,8567,	
administrarse 6 45 6 336,402,767,8495,8561,8926,	
positivos 7 45 7 334,4414,4569,4877,5330,5478,8493,	
En 46 45 46 331,395,591,912,936,1050,1123,1188,1502,1526,2367,2965,3122,3186,3229,3277,3536,3880,3921,3950,4208,4385,4561,4633,4936,5651,5754,5899,6965,7391,7476,7556,7584,7621,7645,7661,8490,8554,8750,9071,9095,9209,9282,9347,9661,9685,	
siguiente 6 45 6 330,590,6256,6968,8489,8749,	
cuenta 2 45 2 328,8487,	
interrupción 4 45 4 321,1237,8480,9396,	
óptima 2 45 2 316,8475,	
duración 5 45 5 315,1571,2697,2901,8474,	
desconoce 4 45 4 313,2128,2208,8472,	
Duración 4 45 4 309,2683,2887,8468,	
virológica 12 45 12 649,853,1517,4178,4335,4367,4791,4841,4862,8808,9012,9676,	
2) 15 45 15 308,507,543,824,1644,1963,2080,4535,4732,6727,7019,8467,8666,8702,8983,	
copias/ml 12 45 12 4327,4493,4692,4907,4959,5036,5101,5123,5187,5360,5405,5676,	
apartado 25 45 25 306,392,541,822,909,1088,1591,1642,1739,1808,1961,2078,2124,3119,3369,3918,5800,6725,7149,8465,8551,8700,8981,9068,9247,	
(E433) 1 45 1 7937,	
comida) 2 45 2 304,8463,	
Ishak 4 45 4 4446,4461,4658,4669,	
después 11 45 11 301,768,1114,1234,3087,3483,4182,8460,8927,9273,9393,	
horas 13 45 13 294,300,746,3621,6470,6656,6663,6874,6901,6945,8453,8459,8905,	
(más 2 45 2 291,8450,	
30°C 1 45 1 7963,	
ayunas 2 45 2 290,8449,	
limita 3 45 3 1169,3438,9328,	
[LVDr]) 2 45 2 277,8436,	
resistencia 21 45 21 273,1481,1498,1540,3808,4035,4098,4122,4135,5849,5916,5952,5986,6187,6200,6236,6284,8432,9640,9657,9699,	
confieren 10 45 10 272,1480,3807,4034,4097,4121,5915,5951,8431,9639,	
mutaciones 9 45 9 270,1469,1584,3805,4587,6126,6409,8429,9628,	
144 6 45 6 1574,5936,5967,6216,6246,6267,	
durante 47 45 47 263,425,927,994,1108,1216,1231,1246,1565,1624,2139,2238,2356,2506,2735,2915,2927,2972,3027,3083,3182,3273,3478,3518,4779,4827,4884,5078,5337,5542,5604,5615,5882,6051,6089,6334,6372,7465,7491,8422,8584,9086,9153,9267,9375,9390,9405,	
107 1 45 1 2361,	
viremia 3 45 3 262,5504,8421,	
indicios 5 45 5 260,3549,7499,7698,8419,	
decir 2 45 2 258,8417,	
(es 2 45 2 257,8416,	
resistentes 17 45 17 254,1465,1710,2713,2969,3233,3782,3996,4558,4573,5325,6159,6249,6272,6721,8413,9624,	
alcanzar 1 45 1 6851,	
alimentos 4 45 4 252,6658,6697,8411,	
equilibrio 1 45 1 6813,	
HBsAg 2 45 2 4929,4981,	
o 66 45 66 250,268,296,377,382,412,523,564,731,792,964,1249,1331,1563,1639,1649,1670,1917,1975,2022,2060,2351,3066,3174,3396,3812,3935,3980,4031,4060,4065,4070,4620,4777,4809,4845,5448,5599,5897,6096,6111,6150,6379,6394,6433,6632,6758,6777,6913,7116,7508,7817,8409,8427,8455,8536,8541,8571,8682,8723,8890,8951,9123,9408,9490,9722,	
recomendada 4 45 4 239,280,8398,8439,	
carácter 2 45 2 1509,9668,	
dosis 49 45 49 238,279,478,487,500,518,548,576,608,624,749,779,820,828,1895,2121,3525,5857,6034,6504,6517,6561,6577,6820,6828,6950,6977,7111,7396,7417,7450,7528,7676,8007,8032,8397,8438,8637,8646,8659,8677,8707,8735,8767,8783,8908,8938,8979,8987,	
Pacientes 21 45 21 231,253,659,1137,1672,1778,3406,4869,4875,5069,5324,5328,5462,5704,5803,5977,6275,8390,8412,8818,9296,	
día 20 45 20 230,248,288,677,683,698,2505,2734,4610,4629,5595,5831,5839,6542,8389,8407,8447,8836,8842,8857,	
vez 35 45 35 228,246,286,675,681,689,696,704,711,720,727,1251,2503,2732,4502,4608,4627,4701,5200,5593,5829,5837,6540,8387,8405,8445,8834,8840,8848,8855,8863,8870,8879,8886,9410,	
oral 10 45 10 226,583,598,758,1934,6595,8385,8742,8757,8917,	
vía 3 45 3 225,2020,8384,	
tomarse 2 45 2 223,8382,	
experiencia 2 45 2 212,8371,	
médico 2 45 2 210,8369,	
iniciado 2 45 2 207,8366,	
debe 31 45 31 205,222,325,335,401,488,650,766,854,1094,1511,1619,1746,1849,2038,2137,2192,3542,4137,5786,8364,8381,8484,8494,8560,8647,8809,8925,9013,9253,9670,	
El 14 45 14 203,2486,2716,3819,4153,4760,6526,6821,6875,7256,7306,7795,7893,8362,	
x 11 45 11 2790,2825,2851,2866,2938,2983,4317,7993,8012,8018,8037,	
efecto 6 45 6 2175,2284,4104,7199,7419,7886,	
administración 11 45 11 202,1295,2536,2764,6514,6538,6611,6766,6886,8361,9454,	
forma 5 45 5 200,3609,5492,7441,8359,	
Posología 4 45 4 198,654,8357,8813,	
1) 9 45 9 195,1593,1741,1810,7059,7063,7084,7086,8354,	
combinada 2 45 2 6049,6332,	
presentó 5 45 5 2555,2585,2783,2803,5700,	
secciones 2 45 2 190,8349,	
descender 2 45 2 900,9059,	
(ver 30 45 30 189,305,391,497,540,821,908,1087,1590,1641,1738,1807,1960,2077,2123,3118,3368,3917,5799,5938,6724,7148,8348,8464,8550,8656,8699,8980,9067,9246,	
lamivudina 62 45 62 188,256,267,276,665,1467,1483,1507,1538,1806,1996,2058,2352,2377,2715,2964,2971,3009,3150,3235,3267,3353,3784,3932,3998,4124,4410,4518,4560,4575,4595,4623,4646,4715,4940,5027,5068,5139,5155,5178,5223,5276,5306,5327,5515,5541,5579,5954,6175,6194,6251,6274,6723,8347,8415,8426,8435,8824,9626,9642,9666,9697,	
resistente 5 45 5 186,1505,4155,8345,9664,	
(< 7 45 7 1844,4491,4690,5045,5989,5992,5995,	
nucleósidos 28 45 28 180,236,669,1061,1299,1319,1387,2480,2926,3133,3197,3575,3974,4310,4351,4379,4429,4874,5907,5976,6712,8339,8395,8828,9220,9458,9478,9546,	
previo 21 45 21 178,234,662,1059,2478,2924,3131,3195,4377,4427,4872,5539,5866,5905,5974,6192,6710,8337,8393,8821,9218,	
negativa 2 45 2 172,8331,	
HBeAg 33 45 33 170,174,333,350,397,1085,1823,3227,4353,4416,4422,4510,4571,4707,4804,4807,4819,4876,4922,4974,5070,5319,5329,5376,5477,5482,5703,8329,8333,8492,8509,8556,9244,	
positiva 2 45 2 168,8327,	
VHB 47 45 47 167,355,907,1032,1475,1870,2182,2206,3367,3603,3646,3672,3682,3746,3765,3781,3993,4151,4154,4323,4341,4485,4686,4793,4796,4904,4956,5033,5098,5120,5184,5357,5402,5507,5634,5667,5892,6088,6141,6371,6425,7107,8326,8514,9066,9191,9634,	
pacientes 161 45 161 162,175,182,332,396,551,781,810,898,914,937,969,1007,1052,1084,1142,1161,1172,1189,1239,1390,1409,1464,1531,1660,1689,1717,1750,1822,1834,1853,1902,2043,2330,2475,2554,2600,2641,2656,2682,2712,2782,2819,2860,2886,2921,2952,2961,2968,2997,3006,3012,3100,3125,3138,3147,3188,3226,3232,3244,3257,3289,3322,3337,3363,3402,3411,3430,3441,4132,4250,4279,4305,4346,4364,4374,4413,4522,4557,4568,4585,4592,4719,4806,4818,4822,4834,4856,4937,4994,5014,5024,5057,5136,5146,5212,5226,5262,5291,5302,5318,5380,5421,5456,5476,5488,5531,5562,5572,5653,5690,5699,5719,5742,5818,5853,5902,5931,5971,6044,6069,6077,6123,6172,6221,6248,6271,6352,6360,6406,6707,6720,6908,6921,6983,7147,7312,8321,8334,8341,8491,8555,8710,8940,8969,9057,9073,9096,9128,9166,9211,9243,9301,9320,9331,9348,9398,9549,9568,9623,9690,	
animales 3 45 3 2115,2222,7490,	
obtenidos 2 45 2 160,8319,	
clínicos 11 45 11 159,1198,2321,3280,3470,3837,4052,4190,5845,8318,9357,	
ensayos 20 45 20 158,2320,2369,2919,2966,3123,3230,3279,3394,3469,4189,4211,4398,5446,5844,5900,5969,6242,6269,8317,	
Ninguna 1 45 1 8084,	
datos 13 45 13 156,467,632,836,1599,1653,1815,2102,2172,8315,8626,8791,8995,	
basa 6 45 6 154,2317,2491,2721,4173,8313,	
indicación 2 45 2 152,8311,	
Esta 6 45 6 151,1166,3435,7440,8310,9325,	
fibrosis 8 45 8 150,4243,4254,4444,4455,4656,4665,8309,	
histología 2 45 2 4524,4721,	
y/o 4 45 4 149,4067,5923,8308,	
inflamación 3 45 3 147,7402,8306,	
histológicas 2 45 2 145,8304,	
pruebas 11 45 11 144,386,416,1105,2386,2547,2775,8303,8545,8575,9264,	
elevados 2 45 2 142,8301,	
persistentemente 2 45 2 141,8300,	
sérica 10 45 10 140,884,893,947,963,8299,9043,9052,9106,9122,	
(ALT) 2 45 2 139,8298,	
aminotransferasa 2 45 2 138,8297,	
alanina 2 45 2 137,8296,	
(19%) 1 45 1 6291,	
niveles 15 45 15 135,881,902,1028,4312,5029,5180,5398,5692,6853,7884,8294,9040,9061,9187,	
mayores 1 45 1 7427,	
activa 6 45 6 134,148,1982,3610,8293,8307,	
vírica 3 45 3 133,4207,8292,	
45 3 45 3 1171,3440,9330,	
replicación 4 45 4 132,4161,4206,8291,	
fertilidad 1 45 1 7504,	
evidencia 3 45 3 130,4204,8289,	
compensada 8 45 8 128,941,1165,3434,4384,8287,9100,9324,	
94% 1 45 1 5093,	
hepática 35 45 35 127,773,784,940,967,979,1093,1164,1209,1245,1292,1369,1407,3082,3433,4282,4383,5806,5821,6903,6911,6924,8286,8932,8943,9099,9126,9138,9252,9323,9368,9404,9451,9528,9566,	
enfermedad 10 45 10 126,939,1406,4281,4382,5805,5820,8285,9098,9565,	
adultos 4 45 4 124,1794,4198,8283,	
(VHB) 2 45 2 122,8281,	
B 23 45 23 121,185,219,868,1016,1122,1133,1206,1457,1721,2333,3112,4201,6986,8280,8344,8378,9027,9175,9281,9292,9365,9616,	
hepatitis 34 45 34 120,184,218,861,867,985,1005,1015,1121,1132,1205,1398,1456,1647,1668,1720,2332,3098,3111,4200,6985,8279,8343,8377,9020,9026,9144,9164,9174,9280,9291,9364,9557,9615,	
virus 9 45 9 117,1474,1665,3108,3801,3995,4085,8276,9633,	
crónica 11 45 11 114,220,869,1458,1722,2334,4202,8273,8379,9028,9617,	
infección 8 45 8 113,164,1719,1725,1768,2201,8272,8323,	
tratamiento 124 45 124 110,177,204,215,233,265,311,318,323,338,400,440,661,889,929,996,1012,1058,1118,1129,1185,1218,1227,1248,1315,1426,1560,1626,1681,1698,1732,1765,1786,1861,2240,2336,2429,2477,2496,2582,2685,2691,2726,2800,2889,2895,2917,2923,2929,2974,3029,3044,3085,3091,3105,3115,3130,3194,3282,3298,3453,4187,4233,4371,4376,4426,4759,4761,4784,4832,4850,4867,4871,4881,4991,4999,5075,5193,5206,5334,5384,5425,5538,5587,5659,5727,5865,5884,5904,5973,6059,6091,6191,6210,6342,6374,6709,8269,8336,8363,8374,8392,8424,8470,8477,8482,8497,8559,8599,8820,9048,9088,9155,9171,9217,9277,9288,9344,9377,9386,9407,9474,9585,9719,	
indicado 2 45 2 107,8266,	
está 6 45 6 106,452,5809,8172,8265,8611,	
compensada) 1 45 1 4283,	
Baraclude 13 45 13 105,221,450,581,756,1936,2135,2242,8264,8380,8609,8740,8915,	
terapéuticas 2 45 2 104,8263,	
Indicaciones 2 45 2 103,8262,	
	"4 2 45 2 101,8260,	
pulmonares 2 45 2 7776,7830,	
CLÍNICOS 2 45 2 100,8259,	
DATOS 3 45 3 99,7908,8258,	
4 45 45 45 98,191,192,196,393,785,798,799,823,910,932,1089,1939,2095,2243,2306,3032,3120,3370,3499,3919,4259,5546,5801,6567,6726,6944,7006,7012,7150,7495,7779,7951,8257,8350,8351,8355,8552,8944,8957,8958,8982,9069,9091,9248,	
" 4 45 4 97,3562,8256,9724,	
""1611"" 1 45 1 93,	
cara 2 45 2 91,8250,	
espontáneas 2 45 2 864,9023,	
grabado 2 45 2 88,8247,	
""BMS"" 2 45 2 87,8246,	
blanquecino 1 45 1 85,	
70% 1 45 1 6496,	
blanco 1 45 1 83,	
triangular 2 45 2 82,8243,	
Comprimido 2 45 2 81,8242,	
(comprimido) 2 45 2 80,8241,	
recubierto 2 45 2 77,8238,	
	"Comprimido 2 45 2 76,8237,	
FARMACÉUTICA 2 45 2 75,8236,	
FORMA 2 45 2 74,8235,	
3 22 45 22 73,373,708,786,2590,2646,2661,2850,2865,3633,6217,6571,7010,7052,7071,7386,7944,8001,8234,8532,8867,8945,	
6 22 45 22 71,375,1112,1232,2096,6532,6628,7014,7050,7073,7075,7907,7938,7943,7950,7982,8078,8079,8232,8534,9271,9391,	
sección 4 45 4 70,505,8231,8664,	
mostraron 2 45 2 3910,4365,	
ver 3 45 3 69,5049,8230,	
competir 1 45 1 3623,	
excipientes 5 45 5 68,797,7914,8229,8956,	
completa 2 45 2 66,8227,	
lista 2 45 2 65,8226,	
consultar 2 45 2 63,8224,	
Para 8 45 8 62,319,1414,1926,5224,8223,8478,9573,	
renal 22 45 22 494,527,807,813,1211,1371,1618,1974,2021,2028,6823,6927,7131,7135,7171,7276,8653,8686,8966,8972,9370,9530,	
lactosa 4 45 4 61,1892,1938,8222,	
acerca 1 45 1 2173,	
120 2 45 2 57,1888,	
Excipientes 2 45 2 53,8215,	
monohidrato) 2 45 2 52,8214,	
(como 2 45 2 51,8213,	
entecavir 133 45 133 50,531,765,917,1055,1187,1301,1500,1542,1562,1608,1628,1658,1683,1712,1748,1788,1820,1863,1953,2013,2030,2056,2087,2108,2177,2210,2228,2263,2278,2338,2345,2375,2407,2431,2498,2694,2728,2898,2955,3000,3015,3117,3141,3191,3260,3284,3331,3361,3383,3455,3482,3589,3714,3739,3774,3818,3826,3886,3900,3916,3943,3958,4020,4037,4042,4076,4100,4110,4405,4604,4883,5017,5060,5077,5149,5170,5215,5266,5295,5336,5386,5435,5534,5589,5622,5639,5661,5713,5749,5784,5825,5859,5918,5934,6039,6061,6161,6178,6212,6238,6344,6455,6617,6735,6752,6768,6794,6841,6859,6931,6974,7097,7144,7207,7338,7360,7463,7488,7566,7670,7686,7691,8212,8690,8924,9076,9214,9346,9460,9659,9701,9721,	
contiene 8 45 8 45,56,1887,7991,8058,8066,8208,8218,	
comprimido 5 45 5 44,55,7917,8207,8217,	
completamente 1 45 1 1589,	
	Cada 2 45 2 43,8206,	
CUANTITATIVA 2 45 2 42,8205,	
Y 2 45 2 41,8204,	
CUALITATIVA 2 45 2 40,8203,	
COMPOSICIÓN 2 45 2 39,8202,	
2 31 45 31 38,197,293,299,422,2575,2605,2616,2622,2633,2824,3061,3163,4221,4316,6310,6451,6568,6584,6639,6883,7046,7069,7122,7790,7939,7948,8201,8356,8452,8458,	
película 5 45 5 37,79,8063,8200,8240,	
96% 1 45 1 5165,	
recubiertos 5 45 5 35,7996,8021,8061,8198,	
comprimidos 8 45 8 34,6591,7995,8014,8020,8039,8060,8197,	
mg 52 45 52 33,48,59,244,284,673,679,687,694,702,709,718,725,737,743,753,1890,1900,2501,2730,3530,4606,4625,5591,5827,5835,5863,5872,6037,6525,6565,6580,6615,6981,7438,7788,8196,8210,8220,8403,8443,8832,8838,8846,8853,8861,8868,8877,8884,8896,8902,8912,	
5 56 45 56 32,47,58,194,243,307,506,542,672,693,736,742,752,934,1592,1643,1740,1809,1889,1899,1940,1962,2079,2125,2340,2500,2634,3034,3563,5561,5862,6450,6466,6469,6564,6587,6614,6655,7008,7031,7033,7385,7435,7787,7983,8353,8402,8466,8665,8701,8831,8852,8895,8901,8911,9093,	
demostración 1 45 1 4168,	
0 52 45 52 31,46,242,671,685,692,700,707,716,723,735,741,751,1898,2339,2499,3685,3755,3790,3794,3797,3858,4325,4519,4716,4798,5647,5861,5871,6003,6005,6465,6521,6563,6570,6586,6613,6661,6963,7434,7786,8401,8830,8844,8851,8859,8866,8875,8882,8894,8900,8910,	
UB8 1 45 1 8129,	
	Baraclude 2 45 2 30,8194,	
MEDICAMENTO 3 45 3 29,3568,8193,	
interrumpirse 2 45 2 1313,9472,	
NOMBRE 2 45 2 27,8191,	
1 56 45 56 25,26,72,102,283,678,724,2328,2346,2729,3570,4128,4196,4501,4605,4700,4812,5048,5199,5481,5590,5826,5870,5988,5991,5994,6007,6036,6129,6226,6413,6468,6522,6524,6579,6654,6980,7004,7067,7437,7466,7552,7793,7911,7994,8013,8019,8038,8190,8195,8209,8233,8261,8442,8837,8883,	
alcanzadas 5 45 5 7430,7473,7539,7581,7782,	
PRODUCTO 1 45 1 24,	
DEL 4 45 4 23,28,8164,8192,	
grupo 3 45 3 510,5657,8669,	
CARACTERÍSTICAS 1 45 1 22,	
LAS 1 45 1 21,	
DE 9 45 9 20,3566,8114,8117,8135,8137,8147,8151,8161,	
RESUMEN 1 45 1 19,	
O 1 45 1 18,	
absorción 1 45 1 6651,	
TÉCNICA 1 45 1 17,	
FICHA 1 45 1 16,	
tuvo 2 45 2 1569,3716,	
ocasiones 2 45 2 1283,9442,	
información 3 45 3 13,1831,8167,	
Toda 1 45 1 11,	
medicamento 8 45 8 10,15,1886,1925,3465,6693,8089,8171,	
Basica 1 45 1 8,	
células/mm3 1 45 1 5558,	
	Información 1 45 1 7,	
P 1 45 1 6,	
CON 1 45 1 5,	
RECUB 1 45 1 4,	
COMPRIMIDOS 1 45 1 3,	
ciegos 1 45 1 4848,	
30 3 45 3 2,7992,8059,	
1MG 1 45 1 1,	
Entre 1 45 1 3010,	
BARACLUDE 1 45 1 0,	
